Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
financing
6
×
life sciences
national blog main
startups
6
×
biotech
boston blog main
funding
boston top stories
national top stories
san diego blog main
san diego top stories
venture capital
boston
cancer
detroit blog main
detroit top stories
drug development
europe blog main
europe top stories
healthcare
innovation
new york blog main
new york top stories
otsuka pharmaceutical
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
20/20 healthcare partners
accelerator
accent therapeutics
aducanumab
airbnb
What
new
biotechs
companies
diseases
drugs
life
medicines
raised
raises
sciences
activity
admits
advance
ago
amsterdam
approach
approvals
associated
bags
big
bio
biogen
biologics
board
bristol
capital
clamped
classes
combinator
considered
covid
delays
deliver
develop
developing
device
dialysis
disease
dtx
dug
Language
unset
6
×
Current search:
financing
×
startups
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In